The combination of ER receptor status and HER2neu status is considered an important factor for the risk of invasive breast cancer.9,16 However, adding the combined ER/HER2neu status to our model did not increase the discriminative ability of the model. The gene discussed is ESR1; the disease is invasive breast carcinoma.